TARS β€” TARSUS PHARMACEUTICALS INC

Ownership history in Affinity Asset Advisors, LLC  Β·  1 quarter on record

This page tracks every 13F SEC filing in which Affinity Asset Advisors, LLC reported a position in TARSUS PHARMACEUTICALS INC (TARS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.65% (2025 Q3)
πŸ“Š Avg. % of fund
0.65%
πŸ“… First filed
2025 Q3
πŸ“… Last filed
2025 Q3
⏱ Quarters held
1
% of Fund (quarterly)    TARS price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 1 quarter  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 INITIATED 125,000 β€” β€” 0.65% $7.4M $59.43

🏒 Other funds also holding TARS

As of 2025 Q4 β€” sorted by position size

Paradigm Biocapital Advisors LP 3Y 5.35% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 4.81% Deep Track Capital, LP 3Y 4.39% GordonMD Global Investments LP 3.91% MPM BioImpact LLC 3Y 3.08% RTW INVESTMENTS, LP 3Y 7Y 2.74% Frazier Life Sciences Management, L.P. 3Y 1.6% Sands Capital Alternatives, LLC 3Y 1.34% Lisanti Capital Growth, LLC 3Y 7Y 1.25% HighVista Strategies LLC 3Y 7Y 1.13%
← Back to Affinity Asset Advisors, LLC Holdings